B cell conserved epitope peptide of intracellular lawsonia intracellularis self-transcription protein a and its application in diagnosis
By displaying the B-cell conserved epitope peptide NN8 on the autotranscribed protein A on the surface of Lawsonia suis, combined with agglutination assay, the problem of insufficient specificity and sensitivity in the detection of Lawsonia suis in existing technologies has been solved, realizing rapid, simple and highly specific antibody detection, which is suitable for the accurate diagnosis of Lawsonia suis infection.
Patent Information
- Application Number
- CN202510452561.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-04-11
- Publication Date
- 2026-07-24
- Estimated Expiration
- 2045-04-11
AI Technical Summary
Existing methods for detecting Lawsonia intracellularis in porcines lack specificity and sensitivity, making it difficult to quickly and accurately diagnose Lawsonia intracellularis infection in clinical settings. Traditional serological methods are cumbersome and prone to nonspecific reactions, and current technologies cannot achieve rapid and accurate detection of Lawsonia intracellularis infection in porcines.
The B-cell conserved epitope peptide NN8 on the self-transcribed protein A on the surface of Lawsonia intracellularis was displayed on the bacterial surface via a recombinant vector. Combined with an agglutination assay directly mediated by NN8-antibody, specific detection of LI antibody was achieved.
It enables rapid, simple, highly specific, and sensitive detection of Lawsonia suis intracellularis antibodies, and can detect specific serum antibodies 7 days after vaccination. It is suitable for assessing the level of vaccine immune protection and detecting LI infection.